Cardioprotection: A radical view. Free radicals in pre and postconditioning

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1787, Issue 7, 2009, Pages 781-793

  Penna, Claudia ^a,b   Mancardi, Daniele ^a,b   Rastaldo, Raffaella ^a,b   Pagliaro, Pasquale ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Istituto Nazionale Per le Ricerche Cardiovascolari (INRC)   (Italy)

Author keywords

Cardioprotection; Ischemia reperfusion; Mitochondria; Postconditioning; Preconditioning; ROS Signaling

Indexed keywords

ACETYLCHOLINE; BRADYKININ; ERYTHROPOIETIN; FREE RADICAL; NITRIC OXIDE DONOR; OPIATE; PHENYLEPHRINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

CELL COMPARTMENTALIZATION; CORONARY ARTERY BYPASS SURGERY; DEFENSE MECHANISM; DRUG INTERMITTENT THERAPY; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART SURGERY; HUMAN; ISCHEMIC PRECONDITIONING; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR ENDOTHELIUM;

ANIMALS; FREE RADICALS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MODELS, BIOLOGICAL; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 67649297963     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2009.02.008     Document Type: Review

References (207)

1. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Mol. Cell. Cardiol. 33 (2001) 1897-1918
2. Dawn B., and Bolli R. Role of nitric oxide in myocardial preconditioning. Ann. N Y Acad. Sci. 962 (2002) 18-41
3. Hausenloy D.J., and Yellon D.M. Preconditioning and postconditioning: new strategies for cardioprotection. Diabetes Obes. Metab. 10 (2008) 451-459
4. Hausenloy D.J., and Yellon D.M. Preconditioning and postconditioning: united at reperfusion. Pharmacol. Ther. 116 (2007) 173-191
5. Murphy E., and Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88 (2008) 581-609
6. Murphy E., and Steenbergen C. Preconditioning: the mitochondrial connection. Annu. Rev. Physiol. 69 (2007) 51-67
7. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol. Rev. 83 (2003) 1113-1151
8. Yellon D.M., and Hausenloy D.J. Myocardial reperfusion injury. N. Engl. J. Med. 357 (2007) 1121-1135
9. Wink D.A., Miranda K.M., Katori T., Mancardi D., Thomas D.D., Ridnour L., Espey M.G., Feelisch M., Colton C.A., Fukuto J.M., Pagliaro P., Kass D.A., and Paolocci N. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H2264-H2276
10. Pagliaro P. Differential biological effects of products of nitric oxide (NO) synthase: it is not enough to say NO. Life Sci. 73 (2003) 2137-2149
11. Pagliaro P., Gattullo D., Rastaldo R., and Losano G. Ischemic preconditioning: from the first to the second window of protection. Life Sci. 69 (2001) 1-15
12. Penna C., Mancardi D., Raimondo S., Geuna S., and Pagliaro P. The paradigm of postconditioning to protect the heart. J. Cell. Mol. Med. 12 (2008) 435-458
13. Fukuto J.M., Jackson M.I., Kaludercic N., and Paolocci N. Examining nitroxyl in biological systems. Methods Enzymol. 440 (2008) 411-431
14. Donzelli S., Switzer C.H., Thomas D.D., Ridnour L.A., Espey M.G., Isenberg J.S., Tocchetti C.G., King S.B., Lazzarino G., Miranda K.M., Roberts D.D., Feelisch M., and Wink D.A. The activation of metabolites of nitric oxide synthase by metals is both redox and oxygen dependent: a new feature of nitrogen oxide signaling. Antioxid. Redox Signal. 8 (2006) 1363-1371
15. Espey M.G., Miranda K.M., Thomas D.D., Xavier S., Citrin D., Vitek M.P., and Wink D.A. A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species. Ann. N Y Acad. Sci. 962 (2002) 195-206
16. Grisham M.B., Jourd'Heuil D., and Wink D.A. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 276 (1999) G315-G321
17. Hare J.M., and Stamler J.S. NO/redox disequilibrium in the failing heart and cardiovascular system. J. Clin. Invest. 115 (2005) 509-517
18. Mason R.B., Pluta R.M., Walbridge S., Wink D.A., Oldfield E.H., and Boock R.J. Production of reactive oxygen species after reperfusion in vitro and in vivo: protective effect of nitric oxide. J. Neurosurg. 93 (2000) 99-107
19. Ridnour L.A., Thomas D.D., Mancardi D., Donzelli S., Paolocci N., Pagliaro P., Miranda K.M., Krishna M.C., Fukuto J., Grisham M.B., Mitchell J.B., Espey M.G., and Wink D.A. Antioxidant properties of nitric oxide in cellular physiological and pathophysiological mechanisms. The implications of biological balance between NO and oxidative stress. Curr. Med. Chem. - Anti-Inflammatory & Anti-Allergy Agents 3 (2004) 181-188
20. Ridnour L.A., Thomas D.D., Mancardi D., Espey M.G., Miranda K.M., Paolocci N., Feelisch M., Fukuto J., and Wink D.A. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol. Chem. 385 (2004) 1-10
21. Wink D.A., and Mitchell J.B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25 (1998) 434-456
22. Wink D.A., Nims R.W., Darbyshire J.F., Christodoulou D., Hanbauer I., Cox G.W., Laval F., Laval J., Cook J.A., Krishna M.C., Degraff W.G., and Mitchell J.B. Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem. Res. Toxicol. 7 (1994) 519-525
23. Wink D.A., Vodovotz Y., Grisham M.B., DeGraff W., Cook J.C., Pacelli R., Krishna M., and Mitchell J.B. Antioxidant effects of nitric oxide. Methods Enzymol. 301 (1999) 413-424
24. Wink D.A., Feelisch M., Fukuto J., Chistodoulou D., Jourd'heuil D., Grisham M.B., Vodovotz Y., Cook J.A., Krishna M., DeGraff W.G., Kim S., Gamson J., and Mitchell J.B. The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch. Biochem. Biophys. 351 (1998) 66-74
25. Berry C.E., and Hare J.M. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 555 (2004) 589-606
26. Hare J.M. Spatial confinement of isoforms of cardiac nitric-oxide synthase: unravelling the complexities of nitric oxide's cardiobiology. Lancet 363 (2004) 1338-1339
27. Hare J.M. Nitroso-redox balance in the cardiovascular system. N. Engl. J. Med. 351 (2004) 2112-2114
28. Di Lisa F., Canton M., Menabò R., Kaludercic N., and Bernardi P. Mitochondria and cardioprotection. Heart Fail. Rev. 12 (2007) 249-260
29. Fukuto J.M., Bartberger M.D., Dutton A.S., Paolocci N., Wink D.A., and Houk K.N. The physiological chemistry and biological activity of nitroxyl (HNO/NO-): the neglected, misunderstood, and enigmatic nitrogen oxide. Chem. Res. Toxicol. 18 (2005) 790-801
30. Fukuto J.M., Switzer C.H., Miranda K.M., and Wink D.A. Nitroxyl (HNO/NO-): chemistry, biochemistry, and pharmacology. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 335-355
31. Fukuto J.M., Cho J.Y., and Switzer C.H. The chemical properties of nitric oxide and related nitrogen oxides. In: Ignarro L.J. (Ed). Nitric Oxide: Biology and Pathobiology (2000), Academic Press, San Diego 23-40
32. Miranda K.M., Nims R.W., Thomas D.D., Espey M.G., Citrin D., Bartberger M.D., Paolocci N., Fukuto J.M., Feelisch M., and Wink D.A. Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS. J. Inorg. Biochem. 93 (2003) 52-60
33. Paolocci N., Jackson M.I., Lopez B.E., Miranda K., Tocchetti C.G., Wink D.A., Hobbs A.J., and Fukuto J.M. The pharmacology of nitroxyl (HNO/NO-) and its therapeutic potential: not just the Janus face of NO. Pharmacol. Ther. 113 (2007) 442-458
34. Ghafourifar P., Asbury M.L., Joshi S.S., and Kincaid E.D. Determination of mitochondrial nitric oxide synthase activity. Methods Enzymol. 396 (2005) 424-444
35. Ghafourifar P., and Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol. Sci. 26 (2005) 190-195
36. Moncada S., and Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat. Rev., Mol. Cell Biol. 3 (2002) 214-220
37. Bergendi L., Benes L., Duracková Z., and Ferencik M. Chemistry, physiology and pathology of free radicals. Life Sci. 65 (1999) 1865-1874
38. Radomski M.W., Palmer R.M., and Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92 (1987) 181-187
39. Wink D.A., and Mitchell J.B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25 (1998) 434-456
40. Zweier J.L., Samouilov A., and Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim. Biophys. Acta 1411 (1999) 250-262
41. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., and Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192 (2000) 1001-1014
42. Ago T., and Sadoshima J. Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid. Redox Signal. 9 (2007) 679-687
43. Villa L.M., Salas E., Darley-Usmar V.M., Radomski M.W., and Moncada S. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12383-12387
44. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61 (2004) 461-470
45. Becker L.B., Vanden Hoek T.L., Shao Z., Li C., and Schumacker P.T. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am. J. Physiol, Heart Circ. Physiol. 277 (1999) H2240-H2246
46. Kevin L.G., Camara A.K., Riess M.L., Novalija E., and Stowe D.F. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am. J. Physiol, Heart Circ. Physiol. 284 (2003) H566-H574
47. Carmody R.J., and Cotter T.G. Signalling apoptosis: a radical approach. Redox Rep. 6 (2001) 77-90
48. Vanden Hoek T.L., Becker L.B., Shao Z., Li C., and Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J. Biol. Chem. 273 (1998) 18092-18098
49. Hearse D.J., Humphrey S.M., and Chain E.B. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J. Mol. Cell. Cardiol. 5 (1973) 395-407
50. Ambrosio G., Flaherty J.T., Duilio C., Tritto I., Santoro G., Elia P.P., Condorelli M., and Chiariello M. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J. Clin. Invest. 87 (1991) 2056-2066
51. Neri M., Cerretani D., Fiaschi A.I., Laghi P.F., Lazzerini P.E., Maffione A.B., Micheli L., Bruni G., Nencini C., Giorgi G., D'Errico S., Fiore C., Pomara C., Riezzo I., Turillazzi E., and Fineschi V. Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. J. Cell. Mol. Med. 11 (2007) 156-170
52. Tritto I., and Ambrosio G. Role of oxidants in the signaling pathway of preconditioning. Antioxid. Redox Signal. 3 (2001) 3-10
53. Ambrosio G., Zweier J.L., Duilio C., Kuppusamy P., Santoro G., Elia P.P., Tritto I., Cirillo P., Condorelli M., and Chiariello M. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J. Biol. Chem. 268 (1993) 18532-18541
54. Marczin N., El-Habashi N., Hoare G.S., Bundy R.E., and Yacoub M. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch. Biochem. Biophys. 420 (2003) 222-236
55. Ferdinandy P., Schulz R., and Baxter G.F. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol. Rev. 59 (2007) 418-458
56. Freude B., Masters T.N., Robicsek F., Fokin A., Kostin S., Zimmermann R., Ullmann C., Lorenz-Meyer S., and Schaper J. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J. Mol. Cell. Cardiol. 32 (2000) 197-208
57. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., and Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94 (1994) 1621-1628
58. Hoffman Jr. J.W., Gilbert T.B., Poston R.S., and Silldorff E.P. Myocardial reperfusion injury: etiology, mechanisms, and therapies. J. Extra Corpor. Tec. 36 (2004) 391-411
59. Reeve J.L., Szegezdi E., Logue S.E., Chonghaile T.N., O'brien T., Ritter T., and Samali A. Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL. J. Cell. Mol. Med. 11 (2007) 509-520
60. Tritto I., D'Andrea D., Eramo N., Scognamiglio A., De Simone C., Violante A., Esposito A., Chiariello M., and Ambrosio G. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res. 80 (1997) 743-748
61. Zhao Z.Q., and Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc. Res. 55 (2002) 438-455
62. Kaeffer N., Richard V., and Thuillez C. Delayed coronary endothelial protection 24 hours after preconditioning: role of free radicals. Circulation 96 (1997) 2311-2316
63. Beauchamp P., Richard V., Tamion F., Lallemand F., Lebreton J.P., Vaudry H., Daveau M., and Thuillez C. Protective effects of preconditioning in cultured rat endothelial cells: effects on neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation. Circulation 100 (1999) 541-546
64. Ronson R.S., Nakamura M., and Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc. Res. 44 (1999) 47-59
65. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 138 (2003) 532-543
66. Beckman J.S., Beckman T.W., Chen J., Marshall P.H., and Freeman B.A. Apparent hydroxyl radical production by peroxylnitrites: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1620-1624
67. Pryor W.A., and Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol., Lung Cell. Mol. Physiol. 268 (1995) L699-L721
68. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (2007) 315-424
69. Molavi B., and Mehta J.L. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr. Opin. Cardiol. 19 (2004) 488-493
70. Thomas D.D., Miranda K.M., Colton C.A., Citrin D., Espey M.G., and Wink D.A. Heme proteins and nitric oxide (NO): the neglected, eloquent chemistry in NO redox signaling and regulation. Antioxid. Redox Signal. 5 (2003) 307-317
71. Kaneko M., Elimban V., and Dhalla N.S. Mechanism for depression of heart sarcolemmal Ca2+ pump by oxygen free radicals. Am. J. Physiol. 257 (1989) H804-H811
72. Kaneko M., Singal P.K., and Dhalla N.S. Alterations in heart sarcolemmal Ca2(+)-ATPase and Ca2(+)-binding activities due to oxygen free radicals. Basic Res. Cardiol. 85 (1990) 45-54
73. Borutaite V., Jekabsone A., Morkuniene R., and Brown G.C. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. J. Mol. Cell. Cardiol. 35 (2003) 339-341
74. Cohen M.V., Yang X.M., and Downey J.M. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115 (2007) 1895-1903
75. Hausenloy D.J., and Yellon D.M. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J. Mol. Cell. Cardiol. 35 (2003) 339-341
76. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ. Res. 94 (2004) 7-16
77. Schulz R., Kelm M., and Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc. Res. 61 (2004) 402-413
78. Reffelmann T., and Kloner R.A. The "no-reflow" phenomenon: basic science and clinical correlates. Heart 87 (2002) 162-168
79. Jordan J.E., Zhao Z.Q., and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 43 (1999) 860-878
80. Reimer K.A., Murry C.E., and Richard V.J. The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy?. J. Mol. Cell. Cardiol. 21 (1989) 1225-1239
81. Sato H., Jordan J.E., Zhao Z.Q., Sarvotham S.S., and Vinten-Johansen J. Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. Ann. Thorac. Surg. 64 (1997) 1099-1107
82. Rajagopalan S., Kurz S., Münzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97 (1996) 1916-1923
83. Pryor W.A. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic. Biol. Med. 28 (2000) 141-164
84. Flaherty J.T., Pitt B., Gruber J.W., Heuser R.R., Rothbaum D.A., Burwell L.R., George B.S., Kereiakes D.J., Deitchman D., and Gustafson N. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 89 (1999) 1982-1991
85. Yusuf S., Dagenais G., Pogue J., Bosch J., and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N. Engl. J. Med. 342 (2000) 154-160
86. Penna C., Rastaldo R., Mancardi D., Raimondo S., Cappello S., Gattullo D., Losano G., and Pagliaro P. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Basic Res. Cardiol. 101 (2006) 180-189
87. Lebuffe G., Schumacker P.T., Shao Z.H., Anderson T., Iwase H., and Vanden Hoek T.L. ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. Am. J. Physiol, Heart Circ. Physiol. 284 (2003) H299-H308
88. Oldenburg O., Qin Q., Sharma A.R., Cohen M.V., Downey J.M., and Benoit J.N. Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc. Res. 55 (2002) 544-552
89. Tanaka K., Weihrauch D., Ludwig L.M., Kersten J.R., Pagel P.S., and Warltier D.C. Mitochondrial adenosine triphosphate-regulated potassium channel opening acts as a trigger for isoflurane-induced preconditioning by generating reactive oxygen species. Anesthesiology 98 (2003) 935-943
90. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
91. Gross E.R., and Gross G.J. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc. Res. 70 (2006) 212-221
92. Gomez L., Thibault H.B., Gharib A., Dumont J.M., Vuagniaux G., Scalfaro P., Derumeaux G., and Ovize M. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am. J. Physiol, Heart Circ. Physiol. 293 (2007) H1654-H1661
93. Hausenloy D.J., and Yellon D.M. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail. Rev. 12 (2007) 217-234
94. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., and Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113 (2004) 1535-1549
95. Lim S.Y., Davidson S.M., Hausenloy D.J., and Yellon D.M. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc. Res. 75 (2007) 530-535
96. Weiss J.N., Korge P., Honda H.M., and Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ. Res. 93 (2003) 292-301
97. + channel opening and H2O2 inhibit the mitochondrial permeability transition. J. Biol. Chem. 281 (2006) 20801-20808
98. Carroll R., Gant V.A., and Yellon D.M. Mitochondrial KATP channels protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc. Res. 51 (2001) 691-700
99. Cohen M.V., Yang X.M., Liu G.S., Heusch G., and Downey J.M. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial KATP channels. Circ. Res. 89 (2001) 273-278
100. Forbes R.A., Steenbergen C., and Murphy E. Diazoxide induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ. Res. 88 (2001) 802-809
101. Garlid K.D., Dos Santos P., Xie Z.J., Costa A.D., and Paucek P. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim. Biophys. Acta 1606 (2003) 1-21
102. O'Rourke B. Myocardial K(ATP) channels in preconditioning. Circ. Res. 87 (2000) 845-855
103. Oldenburg O., Cohen M.V., Yellon D.M., and Downey J.M. Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc. Res. 55 (2002) 429-437
104. Oldenburg O., Qin Q., Krieg T., Yang X.M., Philipp S., Critz S.D., Cohen M.V., and Downey J.M. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) H468-H476
105. Yue Y., Qin Q., Cohen M.V., Downey J.M., and Critz S.D. The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc. Res. 55 (2002) 681-689
106. Murry C.E., Richard V.J., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: is the protective effect mediated by free radical-induced myocardial stunning?. Circulation 78 (1988) Suppl II (Abs II-77)
107. Baines C.P., Goto M., and Downey J.M. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J. Mol. Cell. Cardiol. 29 (1997) 207-216
108. Costa A.D., Garlid K.D., West I.C., Lincoln T.M., Downey J.M., Cohen M.V., and Critz S.D. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ. Res. 97 (2005) 329-336
109. Boengler K., Dodoni G., Rodriguez-Sinovas A., Cabestrero A., Ruiz-Meana M., Gres P., Konietzka I., Lopez-Iglesias C., Garcia-Dorado D., Di Lisa F., Heusch G., and Schulz R. Connexin-43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc. Res. 67 (2005) 234-244
110. Heinzel F.R., Luo Y., Li X., Boengler K., Buechert A., Garci{dotless}a-Dorado D., Di Lisa F., Schulz R., and Heusch G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin-43-deficient mice. Circ. Res. 97 (2005) 583-586
111. Rodriguez-Sinovas A., Boengler K., Cabestrero A., Gres P., Morente M., Ruiz-Meana M., Konietzka I., Miro A., Totzeck A., Heusch G., Schulz R., and Garcia-Dorado D. Translocation of connexin-43 in the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance in cardioprotection. Circ. Res. 99 (2006) 93-101
112. Bell R.M., Cave A.C., Johar S., Hearse D.J., Shah A.M., and Shattock M.J. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J. 19 (2005) 2037-2039
113. Dost T., Cohen M.V., and Downey J.M. Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning. Basic Res. Cardiol. 103 (2008) 378-384
114. Korichneva I. Zinc dynamics in the myocardial redox signaling network. Antioxid. Redox Signal. 8 (2006) 1707-1721
115. Di Lisa F., Menabò R., Canton M., and Petronilli V. The role of mitochondria in the salvage and the injury of the ischemic myocardium. Biochim. Biophys. Acta 1366 (1998) 69-78
116. Di Pancrazio F., Mavelli I., Isola M., Losano G., Pagliaro P., Harris D.A., and Lippe G. In vitro and in vivo studies of F(0)F(1)ATP synthase regulation by inhibitor protein IF(1) in goat heart. Biochim. Biophys. Acta 1659 (2004) 52-62
117. Penna C., Mognetti B., Tullio F., Gattullo D., Mancardi D., Pagliaro P., and Alloatti G. The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling. J. Physiol. Pharmacol. 59 (2008) 47-54
118. Penna C., Pagliaro P., Rastaldo R., Di Pancrazio F., Lippe G., Gattullo D., Mancardi D., Samaja M., Losano G., and Mavelli I. F0F1 ATP synthase activity is differently modulated by coronary reactive hyperemia before and after ischemic preconditioning in the goat. Am. J. Physiol, Heart Circ. Physiol. 287 (2004) H2192-H2200
119. Downey J.M., and Cohen M.V. A really radical observation-a comment on Penna et al. in Basic Res Cardiol (2006) 101:180-189. Basic Res. Cardiol. 101 (2006) 190-191
120. Hausenloy D.J., Wynne A.M., and Yellon D.M. Ischemic preconditioning targets the reperfusion phase. Basic Res. Cardiol. 102 (2007) 445-452
121. Liu Y., Yang X.M., Iliodromitis E.K., Kremastinos D.T., Dost T., Cohen M.V., and Downey J.M. Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res. Cardiol. 103 (2008) 54-59
122. Hausenloy D.J., and Scorrano L. Targeting cell death. Clin. Pharmacol. Ther. 82 (2007) 370-373
123. Hausenloy D.J., and Yellon D.M. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc. Res. 70 (2006) 240-253
124. D.J. Hausenloy, D.M. Yellon, Preconditioning and postconditioning: underlying mechanisms and clinical application, Atherosclerosis (in press), doi:10.1016/j.atherosclerosis.2008.10.029.
125. Siegfried M.R., Erhardt J., Rider T., Ma X.L., and Lefer A.M. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J. Pharmacol. Exp. Ther. 260 (1992) 668-675
126. Kubes P. Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am. J. Physiol. Gastrointest. Liver Physiol. 264 (1993) G143-G149
127. Lee V.G., Johnson M.L., Baust J., Laubach V.E., Watkins S.C., and Billiar T.R. The roles of iNOS in liver ischemia-reperfusion injury. Shock 16 (2001) 355-360
128. Cohen M.V., Yang X.M., and Downey J.M. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc. Res. 70 (2006) 231-239
129. Mellion B.T., Ignarro L.J., Myers C.B., Ohlstein E.H., Ballot B.A., Hyman A.L., and Kadowitz P.J. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol. Pharmacol. 23 (1983) 653-664
130. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4651-4655
131. Hannan R.L., John M.C., Kouretas P.C., Hack B.D., Matherne G.P., and Laubach V.E. Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model. J. Surg. Res. 93 (2000) 127-132
132. Jones S.P., Girod W.G., Palazzo A.J., Granger D.N., Grisham M.B., Jourd'Heuil D., Huang P.L., and Lefer D.J. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am. J. Physiol, Heart Circ. Physiol. 276 (1999) H1567-H1573
133. Kanno S., Lee P.C., Zhang Y., Ho C., Griffith B.P., Shears L.L., and Billiar T.R. Attenuation of myocardial ischemia/reperfusion injury by super-induction of inducible nitric oxide synthase. Circulation 101 (2000) 2742-2748
134. Sumeray M.S., Rees D.D., and Yellon D.M. Infarct size and nitric oxide synthase in murine myocardium. J. Mol. Cell. Cardiol. 32 (2000) 35-42
135. Gattullo D., Linden R.J., Losano G., Pagliaro P., and Westerhof N. Ischaemic preconditioning changes the pattern of coronary reactive hyperaemia in the goat: role of adenosine and nitric oxide. Cardiovasc. Res. 42 (1999) 57-64
136. Rastaldo R., Pagliaro P., Cappello S., Penna C., Mancardi D., Westerhof N., and Losano G. Nitric oxide and cardiac function. Life Sci. 81 (2007) 779-793
137. Mizuno T., Watanabe M., Sakamoto T., and Sunamori M. l-Arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-triphosphate. J. Thorac. Cardiovasc. Surg. 115 (1998) 931-936
138. Yoshida K., Mizukami Y., and Kitakaze M. Nitric oxide mediates protein kinase C isoform translocation in rat heart during postischemic reperfusion. Biochim. Biophys. Acta 1453 (1999) 230-238
139. Wang P., and Zweier J.L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J. Biol. Chem. 271 (1996) 29223-29230
140. Chen Y., Traverse J.H., Du R., Hou M., and Bache R.J. Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation 106 (2002) 273-279
141. Recchia F.A., McConnell P.I., Bernstein R.D., Vogel T.R., Xu X., and Hintze T.H. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ. Res. 83 (1998) 969-979
142. Pagliaro P., Mancardi D., Rastaldo R., Penna C., Gattullo D., Miranda K.M., Feelisch M., Wink D.A., Kass D.A., and Paolocci N. Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic. Biol. Med. 34 (2003) 33-43
143. Fontan F., Madonna F., Naftel D.C., Kirklin J.W., Blackstone E.H., and Digerness S. The effect of reperfusion pressure on early outcomes after coronary artery bypass grafting. A randomized trial. J. Thorac. Cardiovasc. Surg. 107 (1994) 265-270
144. Halldorsson A.O., Kronon M.T., Allen B.S., Rahman S., and Wang T. Lowering reperfusion pressure reduces the injury after pulmonary ischemia. Ann. Thorac. Surg. 69 (2000) 198-203
145. Hori M., Kitakaze M., Sato H., Takashima S., Iwakura K., Inoue M., Kitabatake A., and Kamada T. Staged reperfusion attenuates myocardial stunning in dogs. Role of transient acidosis during early reperfusion. Circulation 84 (1991) 2135-2145
146. Kusuoka H., and Marban E. Cellular mechanisms of myocardial stunning. Annu. Rev. Physiol. 54 (1992) 243-256
147. Lindal S., Gunnes S., Lund I., Straume B.K., Jorgensen L., and Sorlie D. Myocardial and microvascular injury following coronary surgery and its attenuation by mode of reperfusion. Eur. J. Cardiothorac. Surg. 9 (1995) 83-89
148. Michel P., and Ferrera R. Efficacy of controlled reperfusion by using low pressure after myocardial ischemia in rats. Transplant Proc. 34 (2002) 3260-3261
149. Okamoto F., Allen B.S., Buckberg G.D., Bugyi H., and Leaf J. Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J. Thorac. Cardiovasc. Surg. 92 (1986) 613-620
150. Vinten-Johansen J., Buckberg G.D., Okamoto F., Rosenkranz E.R., Bugyi H., and Leaf J. Superiority of surgical versus medical reperfusion after regional ischemia. J. Thorac. Cardiovasc. Surg. 92 (1986) 525-534
151. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., and Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol, Heart Circ. Physiol. 285 (2003) H579-H588
152. Kin H., Zhao Z.Q., Sun H.Y., Wang N.P., Corvera J.S., Halkos M.E., Kerendi F., Guyton R.A., and Vinten-Johansen J. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc. Res. 62 (2004) 74-85
153. Philipp S., Yang X.M., Cui L., Davis A.M., Downey J.M., and Cohen M.V. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc. Res. 70 (2006) 308-314
154. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J. Am. Coll. Cardiol. 44 (2004) 1103-1110
155. Vinten-Johansen J., Zhao Z.Q., Zatta A.J., Kin H., Halkos M.E., and Kerendi F. Postconditioning-a new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res. Cardiol. 100 (2005) 295-310
156. Zhao Z.Q., and Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc. Res. 70 (2006) 200-211
157. Couvreur N., Lucats L., Tissier R., Bize A., Berdeaux A., and Ghaleh B. Differential effects of postconditioning on myocardial stunning and infarction: a study in conscious dogs and anesthetized rabbits. Am. J. Physiol, Heart Circ. Physiol. 291 (2006) H1345-H1350
158. Penna C., Tullio F., Merlino A., Moro F., Raimondo S., Rastaldo R., Perrelli M.G., Mancardi D., and Pagliaro P. Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res. Cardiol. (2008) 10.1007/s00395-008-0762-8
159. Na H.S., Kim Y.I., Yoon Y.W., Han H.C., Nahm S.H., and Hong S.K. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am. Heart J. 132 (1996) 78-83
160. Galagudza M., Kurapeev D., Minasian S., Valen G., and Vaage J. Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. Eur. J. Cardiothorac. Surg. 25 (2004) 1006-1010
161. Kloner R.A., Dow J., and Bhandari A. Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion. J. Cardiovasc. Pharmacol. Ther. 11 (2006) 55-63
162. Grech E.D., and Ramsdale D.R. Termination of reperfusion arrhythmia by coronary artery occlusion. Br. Heart J. 72 (1994) 94-95
163. Penna C., Mancardi D., Rastaldo R., Losano G., and Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc. Res. 75 (2007) 168-177
164. Penna C., Mancardi D., Tullio F., and Pagliaro P. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res. Cardiol. 103 (2008) 368-377
165. Tsutsumi Y.M., Yokoyama T., Horikawa Y., Roth D.M., and Patel H.H. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci. 81 (2007) 1223-1227
166. Penna C., Cappello S., Mancardi D., Raimondo S., Rastaldo R., Gattullo D., Losano G., and Pagliaro P. Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res. Cardiol. 101 (2006) 168-179
167. Penna C., Mancardi D., Tullio F., and Pagliaro P. Intermittent adenosine at the beginning of reperfusion does not trigger cardioprotection. J. Surg. Res. (2008) 10.1016/j.j.ss.2008.02.070
168. Zhao Z.Q. Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr. Opin. Pharmacol. 4 (2004) 159-165
169. Sivaraman V., Mudalgiri N.R., Di Salvo C., et al. Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res. Cardiol. 102 (2007) 453
170. Chen Z., Li T., and Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J. Sur. Res. 145 (2008) 287-294
171. Cohen M.V., and Downey J.M. Adenosine: trigger and mediator of cardioprotection. Basic Res. Cardiol. 103 (2008) 203-215
172. Peart J.N., and Headrick J.P. Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol. Ther. 114 (2007) 208-221
173. Morrison R.R., Tan X.L., Ledent C., Mustafa S.J., and Hofmann P.A. Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning. Am. J. Physiol, Heart Circ. Physiol. 293 (2007) H2523-H2529
174. Donato M., D'Annunzio V., Berg G., Gonzalez G., Schreier L., Morales C., Wikinski R.L., and Gelpi R.J. Ischemic postconditioning reduces infarct size by activation of A1 receptors and KATP channels in both normal and hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 49 (2007) 287-292
175. Xi L., Das A., Zhao Z.Q., Merino V.F., Bader M., and Kukreja R.C. Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice. Circulation 118 (2008) S32-S37
176. Yang X.P., Liu Y.H., Scicli G.M., Webb C.R., and Carretero O.A. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats. Hypertension 30 (1997) 735-740
177. Yin H., Chao J., Bader M., and Chao L. Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides 28 (2007) 1383-1389
178. Schwartz L.M., and Lagranha C.J. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am. J. Physiol, Heart Circ. Physiol. 290 (2006) H1011-H1018
179. Iliodromitis E.K., Georgiadis M., Cohen M.V., Downey J.M., Bofilis E., and Kremastinos D.T. Protection from post-conditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Res. Cardiol. 101 (2006) 502-507
180. Halkos M.E., Kerendi F., Corvera J.S., Wang N.P., Kin H., Payne C.S., Sun H.Y., Guyton R.A., Vinten-Johansen J., and Zhao Z.Q. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann. Thorac. Surg. 78 (2004) 961-969
181. Sun H.Y., Wang N.P., Kerendi F., Halkos M., Kin H., Guyton R.A., Vinten-Johansen J., and Zhao Z.Q. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am. J. Physiol, Heart Circ. Physiol. 288 (2005) H1900-H1908
182. Yang X.M., Philipp S., Downey J.M., and Cohen M.V. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res. Cardiol. 100 (2005) 57
183. Urschel H.C., Morales A.R., Finney J.W., Balla G.A., Race G.J., and Mallams J.T. Cardiac resuscitation with hydrogen peroxide. Ann. Thor. Surg. 2 (1966) 665-682
184. Urschel W.C. Cardiovascular effects of hydrogen peroxide: current status. Dis. Chest. 51 (1967) 180-192
185. Takahashi M., Horiguchi Y., and Murakami K. Effects of epicardial perfusion with hydrogen peroxide for ischemic myocardium. Jpn. Heart J. 10 (1969) 53-58
186. Olson R.D., and Boerth R.C. Hydrogen peroxide: beneficial effects in rabbits following acute coronary occlusion. Am. J. Physiol, Heart Circ. Physiol. 234 (1978) H28-H34
187. Goodlett M., Dowling K., and Downey J.M. The failure of hydrogen peroxide to improve function in ischemically depressed myocardium. Eur. J. Pharmacol. 60 (1979) 257-260
188. Ytrehus K., Walsh R.S., Richards S.C., and Downey J.M. Hydrogen peroxide as a protective agent during reperfusion. A study in the isolated perfused rabbit heart subjected to regional ischemia. Cardiovasc. Res. 30 (1995) 1033-1037
189. Wölkart G., Kaber G., Kojda G., and Brunner F. Role of endogenous hydrogen peroxide in cardiovascular ischaemia/reperfusion function: studies in mouse hearts with catalase-overexpression in the vascular endothelium. Pharmacol. Res. 54 (2006) 50-56
190. Fujita M., Asanuma H., Hirata A., Wakeno M., Takahama H., Sasaki H., Kim J., Takashima S., Tsukamoto O., Minamino T., Shinozaki Y., Tomoike H., Hori M., and Kitakaze M. Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am. J. Physiol, Heart Circ. Physiol. 292 (2007) 2004-2008
191. Kupai K., Csonka C., Csont T., Fekete V., and Ferdinandy P. Peroxynitrite formation during postconditioning is involved in the triggering mechanism of cardioprotection. J. Mol. Cell. Cardiol. 44 (2007) 813 (Abs 243)
192. Penna C., Perrelli M.G., Tullio F., Moro F., Merlino A., and Pagliaro P. La cardioprotezione da postcondizionamento in presenza di enzimi antiossidanti: catalasi e superossido dismutasi. G. Ital. Cardiol. 9 (2008) 8S (Abs C22)
193. Sasaki N., Sato T., Ohler A., O'Rourke B., and Marban E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101 (2000) 439-445
194. Lefer A.M., and Lefer D.J. Endothelial dysfunction in myocardial ischemia and reperfusion: role of oxygen derived free radicals. Basic Res. Cardiol. 86 (1991) 109-116
195. Mancardi D., Ridnour L.A., Thomas D.D., Katori T., Tocchetti C.G., Espey M.G., Miranda K.M., Paolocci N., and Wink D.A. The chemical dynamics of NO and reactive nitrogen oxides: a practical guide. Curr. Mol. Med. 4 (2004) 723-740
196. Ma X.L., Gao F., Liu G.L., Lopez B.L., Christopher T.A., Fukuto J.M., Wink D.A., and Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 14617-14622
197. Duranski M.R., Greer J.J., Dejam A., Sathya J., Hogg N., Langston W., Patel R.P., Yet S.F., Wang X., Kevil C.G., Gladwin M.T., and Lefer D.J. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest. 115 (2005) 1232-1240
198. Millar T.M., Stevens C.R., Benjamin N., Eisenthal R., Harrison R., and Blake D.R. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett. 427 (1998) 225-228
199. Jones S.P., and Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J. Mol. Cell. Cardiol. 40 (2006) 16-23
200. Nishino Y., Webb I.G., Davidson S.M., Ahmed A.I., Clark J.E., Jacquet S., Shah A.M., Miura T., Yellon D.M., Avkiran M., and Marber M.S. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ. Res. 103 (2008) 307-314
201. Skyschally A., van Caster P., Boengler K., Gres P., Musiolik J., Schilawa D., Schulz R., and Heusch G. Ischemic postconditioning in pigs No causal role for RISK activation. Circ. Res. 104 (2009) 15-18
202. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., and Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol. Ther. 120 (2008) 172-185
203. Goodman M.D., Koch S.E., Fuller-Bicer G.A., and Butler K.L. Regulating RISK: a role for JAK-STAT signaling in postconditioning?. Am. J. Physiol, Heart Circ. Physiol. 295 (2008) H1649-1656
204. Darling C.E., Solari P.B., Smith C.S., Furman M.I., and Przyklenk K. Postconditioning the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res. Cardiol. 102 (2007) 248-274
205. Laskey W.K. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter. Cardiovas. Interv. 65 (2005) 361-367
206. Staat P., Rioufol G., Piot C., Cottin Y., Cung T.T., L'Huillier I., Aupetit J.F., Bonnefoy E., Finet G., André-Fouët X., and Ovize M. Postconditioning the human heart. Circulation 112 (2005) 2143-2148
207. Thibault H., Piot C., Staat P., Bontemps L., Sportouch C., Rioufol G., Cung T.T., Bonnefoy E., Angoulvant D., Aupetit J.F., Finet G., André-Fouët X., Macia J.C., Raczka F., Rossi R., Itti R., Kirkorian G., Derumeaux G., and Ovize M. Long-term benefit of postconditioning. Circulation 117 (2008) 1037-1044